Mycophenolate Mofetil in Low Doses Stabilizes and Improves Antineutrophil Cytoplasmic Antibody-associated Vasculitis and Lupus Nephritis

Archives of Medical Research

Volumn 39, Issue 1, 2008, Pages 115-119

  Kazderova, Marketa ^a   Jancova, Eva ^a   Rysava, Romana ^a   Merta, Miroslav ^a   Tesar, Vladimir ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

ANCA associated vasculitis; Glomerulonephritis; Lupus nephritis; Mycophenolate mofetil; Systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ECZEMA; FEMALE; GASTROINTESTINAL SYMPTOM; GLOMERULONEPHRITIS; HUMAN; INFECTION COMPLICATION; LOADING DRUG DOSE; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; RELAPSE; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION;

AUTOANTIBODIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MYCOPHENOLIC ACID; NEUTROPHILS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULITIS;

EID: 36549046550     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.07.006     Document Type: Article

References (26)

1. Jayne D. Non-transplant uses of mycophenolate mofetil. Curr Opin Nephrol Hypertens 8 (1999) 563-567
2. Romero F., Rodriguez-Iturbe B., Parra G., Gonzalez L., Herrera-Acosta J., and Tapia E. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats. Kidney Int 55 (1999) 945-955
3. Ginzler E.M., Dooley M.A., Aranow C., Kim M.Y., Buyon J., Merrill J.T., et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353 (2005) 2219-2228
4. Contreras G., Roth D., Pardo V., Striker L.G., and Schultz D.R. Lupus nephritis: a clinical review for practicing nephrologists. Clin Nephrol 57 (Feb 2002) 95-107
5. Markowitz G.S., and D'Agati V.D. The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 years. Kidney Int 71 (2007) 491-495
6. Houssiau F.A., Vasconcelos C., D'Cruz D., Sebastiani G.D., Garrido Ed Ede R., Danieli M.G., et al. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 46 (2002) 2121-2131
7. Vanková Z., Ríhová Z., Jancová E., Rysavá R., Merta M., and Tesar V. Optimizing the therapeutic strategies in ANCA-associated vasculitis-single centre experience with international randomized trials. Prague Med Rep 107 (2006) 199-212
8. Chan T.M., Li F.K., Tang C.S., Wong R.W., Fang G.X., Ji Y.L., et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Eng J Med 343 (2000) 1156-1162
9. Nowack R., Birck R., and van der Woude F.J. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy. Lancet 349 (1997) 774
10. Briggs W.A., Choi M.J., and Scheel Jr. P.J. Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis 31 (1998) 213-217
11. Schiele J., Nowack R., Julian B.A., and van der Woude F.J. Treatment of immunoglobulin A nephropathy. Ann Med Interne (Paris) 150 (1999) 127-136
12. Alba P., Karim M.Y., and Hunt B.J. Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lupus 12 (2003) 633-635
13. Howard J., Hoffbrand A.V., Prentice H.G., and Mehta A. Mycophenolate mofetil for maintenance treatment of refractory autoimmune haemolytic anaemia and auto-immune thrombocytopenia purpura. Br J Haematol 117 (2002) 712-715
14. Adu D., Cross J., and Jayne D.R. Treatment of systemic lupus erythematosus with mycophenolate mofetil. Lupus 10 (2001) 203-208
15. D'Agati V.D., and Appel G.B. Wegener granulomatosis. In: Tisher C.C., and Brenner B.M. (Eds). Renal Pathology (1994), JB Lippincott & Co., Philadelphia 1115-1130
16. Cross J., Dwomoa A., Andrews P., Burns A., Gordon C., Main J., et al. Mycophenolate mofetil for remission induction in severe lupus nephritis. Nephron Clin Pract 100 (2005) c92-c100
17. Kingdon E.J., McLean A.G., Psimenou E., Davenport A., Powis S.H., Sweny P., et al. The safety and efficacy of MMF in lupus nephritis: a pilot study. Lupus 10 (2001) 606-611
18. Hu W., Liu Z., Chen H., Tang Z., Wang Q., Shen K., and Li L. Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. Chin Med J (Engl) 115 (2002) 705-709
19. Ong L.M., Hooi L.S., Lim T.O., Goh B.L., Ahmad G., Ghazalli R., et al. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis. Nephrology (Carlton) 10 (2005) 504-510
20. Flores-Suarez L.F. Remission of severe relapsing or persistent lupus nephritis using mycophenolate mofetil. Arch Med Res 37 (2006) 68-73
21. Spetie D.N., Tang Y., Rovin B.H., Nadasdy T., Nadasdy G., Pesavento T.E., et al. Mycophenolate therapy of SLE membranous nephropathy. Kidney Int 66 (2004) 2411-2415
22. Peterova V., and Dostal C. Characteristics of foci of increased MR signals in the brain of patients with systemic lupus erythematosus and cerebral involvement. Sb Lek 104 (2003) 263-271
23. Joy M.S., Hogan S.L., Jennette J.C., Falk R.J., and Nachman P.H. A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis. Nephrol Dial Transplant 20 (2005) 2725-2732
24. Nowack R., Gobel U., Klooker P., Hergesell O., Andrassy K., and van der Woude F.J. Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am Soc Nephrol 10 (Sep 1999) 1965-1971
25. Waiser J., Budde K., Braasch E., and Neumayer H.H. Treatment of acute c-ANCA-positive vasculitis with mycophenolate mofetil. Am J Kidney Dis 34 (1999) e9
26. Koukoulaki M., and Jayne D.R.W. Mycophenolate mofetil in antineutrophil cytoplasm antibodies-associated systemic vasculitis. Nephron Clin Pract 102c (2006) c100-c107